drugset / Trial / NCT00906308
A Study of MF101 in Postmenopausal Women
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This phase 3a study is designed to assess the safety and efficacy of MF101 on the frequency of moderate to severe hot flushes in postmenopausal women.
Timeline
- Start
- 2011-10
- Primary completion
- 2013-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MF101 | Traditional medicine (herbal / TCM) | 5 g | Oral |
| Subject | MF101 | Traditional medicine (herbal / TCM) | 10 g | Oral |